A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei

International Journal of Cancer

Volumn 134, Issue 2, 2014, Pages 478-486

  Pillai, Krishna ^a   Akhter, Javed ^a   Chua, Terence C ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cytoreductive surgery; mucinous ascites; mucolysis; peritoneal metastases; pseudomyxoma peritonei

Indexed keywords

ACETYLCYSTEINE; BROMELAIN; MUCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; MALE; MUCINOUS ASCITES; NONHUMAN; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; RAT;

CYTOREDUCTIVE SURGERY; MUCINOUS ASCITES; MUCOLYSIS; PERITONEAL METASTASES; PSEUDOMYXOMA PERITONEI;

ACETYLCYSTEINE; ANIMALS; BROMELAINS; DRUG COMBINATIONS; EXPECTORANTS; MALE; MUCINS; MUCUS; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; RATS; RATS, NUDE;

EID: 84887450166     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28380     Document Type: Article

References (38)

1. Miner TJ, Shia J, Jaques DP, et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005; 241: 300-8.
2. Sugarbaker PH,. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001; 27: 239-43. (Pubitemid 32621746)
3. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008; 15: 526-34.
4. Bevan KE, Mohamed F, Moran BJ,. Pseudomyxoma peritonei. World J Gastrointest Oncol 2010; 2: 44-50.
5. Sugarbaker PH, Chang D,. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6: 727-31. (Pubitemid 30013648)
6. Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012; 30: 2449-56.
7. vanSonnenberg E, Goodacre BW, Wittich GR, et al. Interventional radiology strategies in the treatment of pseudomyxoma peritonei. Cardiovasc Intervent Radiol 2005; 28: 490-4. (Pubitemid 41223857)
8. Chua TC, Liauw W, Morris DL,. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis 2012; 27: 381-9.
9. Mantle M,. Effects of hydrogen peroxide, mild trypsin digestion and partial reduction on rat intestinal mucin and its disulphide-bound 118 kDa glycoprotein. Biochem J 1991; 274 (Part 3): 679-85.
10. Roberton AM, Mantle M, Fahim RE, et al. The putative 'link' glycopeptide associated with mucus glycoproteins. Composition and properties of preparations from the gastrointestinal tracts of several mammals. Biochem J 1989; 261: 637-47. (Pubitemid 19187395)
11. Rubin BK,. Mucolytics, expectorants, and mucokinetic medications. Respir Care 2007; 52: 859-65.
12. Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354: 229-40. (Pubitemid 43113028)
13. de Boer WI, Yao H, Rahman I,. Future therapeutic treatment of COPD: struggle between oxidants and cytokines. Int J Chron Obstruct Pulmon Dis 2007; 2: 205-28. (Pubitemid 350110895)
14. Hooper C, Calvert J,. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3: 659-69.
15. Wall JS,. Disulfide bonds: determination, location, and influence on molecular properties of proteins. J Agric Food Chem 1971; 19: 619-25.
16. Shirasawa Y, Orita H, Ishida K, et al. Critical alkalosis following intraperitoneal irrigation with sodium bicarbonate in a patient with pseudomyxoma peritonei. J Anesth 2008; 22: 278-81.
17. Green N, Gancedo H, Smith R, et al. Pseudomyxoma peritonei-nonoperative management and biochemical findings. A case report. Cancer 1975; 36: 1834-7.
18. Beller FK, Zimmerman RE, Nienhaus H,. Biochemical identification of the mucus of pseudomyxoma peritonei as the basis for mucolytic treatment. Am J Obstet Gynecol 1986; 155: 970-3. (Pubitemid 17176658)
19. Snyder TE, Vandivort MR,. Mucinous cystadenocarcinoma of the appendix with pseudomyxoma peritonei presenting as total uterine prolapse. A case report. J Reprod Med 1992; 37: 103-6.
20. Rowan AD, Buttle DJ, Barrett AJ,. The cysteine proteinases of the pineapple plant. Biochem J 1990; 266: 869-75. (Pubitemid 20103724)
21. Harrach T, Eckert K, Schulze-Forster K, et al. Isolation and partial characterization of basic proteinases from stem bromelain. J Protein Chem 1995; 14: 41-52.
22. Inagami T, Murachi T,. Kinetic studies of bromelain catalysis. Biochemistry 1963; 2: 1439-44.
23. Brocklehurst K, Crook EM, Kierstan M,. The mutability of stem bromelain: evidence for perturbation by structural transitions of the parameters that characterize the reaction of the essential thiol group of bromelain with 2,2'-dipyridyl disulphide. Biochem J 1972; 128: 979-82.
24. Maurer HR,. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 2001; 58: 1234-45. (Pubitemid 32850918)
25. Wang SL, Lin HT, Liang TW, et al. Reclamation of chitinous materials by bromelain for the preparation of antitumor and antifungal materials. Bioresour Technol 2008; 99: 4386-93.
26. Turner J, Jones CE,. Regulation of mucin expression in respiratory diseases. Biochem Soc Trans 2009; 37: 877-81.
27. Mantle M, Stewart G,. Intestinal mucins from normal subjects and patients with cystic fibrosis. Variable contents of the disulphide-bound 118 kDa glycoprotein and different reactivities with an anti-(118 kDa glycoprotein) antibody. Biochem J 1989; 259: 243-53. (Pubitemid 19100521)
28. Mieda R, Aso C, Nishikawa K, et al. [Transient hyperglycemia following intra-peritoneal irrigation with 5% glucose in a patient with pseudomyxoma peritonei]. Masui 2007; 56: 959-61. (Pubitemid 47280292)
29. Roy WJ, Jr, Thomas BL, Horowitz IR,. Acute hyperglycemia following intraperitoneal irrigation with 10% dextrose in a patient with pseudomyxoma peritonei. Gynecol Oncol 1997; 65: 360-2. (Pubitemid 27216955)
30. Piver MS, Lele SB, Patsner B,. Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage. Obstet Gynecol 1984; 64: 95S-96S. (Pubitemid 14067489)
31. Suk JS, Boylan NJ, Trehan K, et al. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Mol Ther 2011; 19: 1981-9.
32. Stey C, Steurer J, Bachmann S, et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 2000; 16: 253-62. (Pubitemid 30624944)
33. Poole PJ, Black PN,. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322: 1271-4. (Pubitemid 32493959)
34. Mall AS, Lotz Z, Tyler M, et al. Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study. Case Rep Gastroenterol 2011; 5: 5-16.
35. Bhui K, Tyagi S, Prakash B, et al. Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. Biofactors 2010; 36: 474-82.
36. Tysnes BB, Maurer HR, Porwol T, et al. Bromelain reversibly inhibits invasive properties of glioma cells. Neoplasia 2001; 3: 469-79. (Pubitemid 33151013)
37. Onken JE, Greer PK, Calingaert B, et al. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin Immunol 2008; 126: 345-52.
38. Amini A, Ehteda A, Masoumi Moghaddam S, et al. Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21). Onco Targets Ther 2013; 6: 403-9.